Jobs / United States / Abbvie INC
Associate Director, International Market Access and Pricing, Immunology
Abbvie INC · 🇺🇸 Mettawa, IL, US
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Abbvie INC paid sponsored hires in similar roles2 certified filings for “Intercontinental Market Access Director, Oncology” (Market Research Analysts and Marketing Specialists) in IL: $191k–$260k, median $225k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Abbvie INC
The US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Abbvie INC →
About the role
The Associate Director, Pricing is the International pricing lead for RINVOQ . The role sets and protects the brand's International price position across its indications and markets. It turns pricing analysis into clear guidance, robust business cases and accurate financial assumptions, and supports Area and affiliate teams in securing and maintaining the best achievable price and access. Key Responsibilities: Pricing Strategy and Guidance • Develop and maintain International pricing guidance for RINVOQ (price corridors, floor prices and launch and re-pricing recommendations) in line with brand strategy, the Integrated Access Strategy (IAS) and corporate objectives. • Apply the Strategic Pricing Framework to define the price potential of new indications and formulations, and recommend indication and country launch sequencing that maximizes International value. • Develop contracting guidance and access models that address payer objections and affordability concerns while protecting net price and the reference-price position. • Monitor International pricing policy and competitor pricing, and flag risks and opportunities for RINVOQ early. Business Cases and Pricing Governance • Lead the development, review and challenge of RINVOQ pricing business cases from affiliates and Areas, ensuring each is analytically sound, compliant with International pricing governance and ready for decision. • Prepare and present business cases to the International and Global Executive Pricing Councils, with a clear recommendation, quantified financial impact, risks and mitigations. PVTO and IRP Analysis • Build and run price-volume trade-off (PVTO) analyses to evaluate price and access scenarios, breakeven volumes and the net revenue impact of pricing decisions at market and International level. • Assess International Reference Pricing (IRP) implications of every proposed price change, launch price and confidential agreement. Quantify cross-country spill-over and set the sequencing and price levels that protect the overall International price position. • Work with International Pricing analysts to design, run and interpret IRP, PVTO and launch-sequencing models, and turn the outputs into clear recommendations for senior stakeholders. Plan and Long range Plan (LRP) • Own the RINVOQ pricing assumptions in the annual Plan and LRP process, including price evolution, launch timing, price erosion, IRP impact and risk and opportunity scenarios. • Collect, challenge and align pricing assumptions with Areas, affiliates and Finance, so that forecasts are consistent and explained. Cross-Functional Partnership • Area and affiliates (primary partners): help key markets turn International pricing guidance into local outcomes, covering price potential, negotiation strategy, scenarios, fallback positions and objection handling for national and sub-national negotiations. • Therapy Area teams: make sure the pricing position is reflected in the RINVOQ IAS and brand strategy, and that indication priorities reflect price potential. • HTA: align price potential with the expected HTA outcome and value story, and assess the price implications of HTA evidence and comparator choices. • Finance: reconcile pricing inputs with Plan, LRP and business case financials, and agree the net revenue impact of pricing decisions. • Act as the internal subject matter expert on RINVOQ pricing, IRP and pricing analytics. Essential • Bachelor's degree in Finance, Economics, Health Economics, Statistics, Mathematics, Pharmacy or a related field. • At least 3 years' experience in pharmaceutical pricing, market access, health economics or commercial finance. • Strong quantitative and modelling skills, with experience building and interpreting pricing, forecasting or scenario